JAKARTA (Reuters) – Indonesia’s health minister said on Thursday that the country would receive 20 million doses of the AstraZeneca COVID-19 vaccine via a bilateral deal in 2021, instead of the 50 million doses that had been initially agreed.
The remaining 30 million doses will be shipped in 2022, minister Budi Gunadi Sadikin told a parliamentary hearing.
Indonesia is also slated to receive 54 million doses of the AstraZeneca vaccine in phases via the COVAX global-vaccine alliance scheme, though Budi said Indian export restrictions would delay shipments in April.
(Reporting by Stanley Widianto; Editing by Ed Davies)